'New frontier in protein innovation': FrieslandCampina Ingredients joins forces with biotech firm Triplebar
Through microbial fermentation, the two companies will develop proteins, which will be used for adult and infant nutrition ingredients.
Archives for January 9, 2023
China focus: DSM’s vitamin C production, Melrose’s market strategies, Junlebao’s new launch
This round-up looks at the latest developments in China’s health and nutrition industry, including DSM temporarily reducing its vitamin C production in China, Melrose’s new product and retail strategies for China, Junlebao’s new product launch for...
聚焦中国：帝斯曼的维生素 C 产量、麦萝氏市场策略以及君乐宝新品上市
本期综合新闻关注中国健康与营养行业的最新动态，包括帝斯曼暂时减少在中国的维生素 C 产量、麦萝氏在中国的新产品和零售战略、君乐宝健康老龄化新品上市等等。
品牌动态：麦萝氏、爱茉莉太平洋、大昌华嘉最新动态
查看亚太地区营养保健品品牌的最新动态，包括澳大利亚公司麦萝氏的中国市场战略、爱茉莉太平洋的健康老龄化新产品开发系列，以及大昌华嘉和 Probi 推出的益生菌。
趋势追踪：后生元在新产品研发中的崛起
使用后生元作为营养保健品的关键成分正变得越来越普遍。本期综合新闻关注在该领域取得长足进步的公司，包括产品创新和研究。
科学短报：关于眼睛健康、血糖和体重管理的最新研究
本期综合新闻包括有关有益于眼睛健康的功能性成分、益生菌如何调节血糖以及减少含糖饮料摄入量如何降低 BMI 的最新科学发现。
监管综合新闻：韩国的定制营养、香港的鱼油检验、新西兰政策调整
查看有关亚太地区补充剂监管环境的新动态，包括韩国支持定制营养行业的计划、新西兰天然保健品行业的监管改革等。
2023 outlook: The must know nutraceutical regulations on the horizon in APAC this year
Check out the new nutraceutical related regulations that will kick in this year in various parts of Asia-Pacific, from the use of aloe vera in Taiwan to Hong Kong’s Amendment Regulation regarding harmful substances in food, and Malaysia implementing...
Probiotics mitigate disruptions to gut microbiota during bacteria-eradication treatment – China RCT
Probiotics supplementation could reduce gastrointestinal side effects and restore alterations to the gut microbiota caused by Helicobacter pylori (H. pylori)-eradication therapy, a new study reveals.